The 2023 ESC Heart Failure (HF) Guidelines (GLs) recommend the rapid up-titration of GL-directed medical therapy (GDMT) for all patients (pts) after a HF hospitalisation to improve prognosis. The literature suggests that left bundle branch block (LBBB) may have a negative impact on the implementation of GDMT and...
K. Czurko, F. Bánfi-Bacsárdi, Z. Forrai et al.· European Heart Journal· 0 citations
Adherence to guideline-directed medical therapy (GDMT) in heart failure (HF) remains a significant challenge nowadays, which is emphasised by the 2025 scientific statement of the ESC HFA and the ESC Working Group on Cardiovascular Pharmacotherapy. Not only “door-to-GDMT” time, but also “time on GDMT” has a severe...
P. P. Schaffer, F. Bánfi-Bacsárdi, Z. Forrai et al.· European Heart Journal· 0 citations
The long-term use and the achieved doses of QT after a hospitalisation for HF (HFH) in a consecutive cohort of HFrEF patients was analyzed and the effect of the achieved doses on prognosis (all-cause mortality [ACM], HFH, composite of ACM/HFH) was evaluated.
Z. Forrai, F. Bánfi-Bacsárdi, P. P. Schaffer et al.· European Heart Journal· 0 citations
The 2021 European Society of Cardiology (ESC) Heart Failure (HF) Guidelines (GLs) recommend enrolling all HF patients in a multidisciplinary HF management programme to improve the prognosis. However, the accessibility of HF Outpatient Clinics (HFOCs) in real-world clinical practice remains suboptimal.
To a...
B. Muk, Z. Forrai, P. P. Schaffer et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.